Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrapulmonary meropenem concentrations with continuous infusion in postoperative pneumonia
2016-002796-10Phase 4Active
- Sponsor
- Parc de Salut Mar
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of meropenem in postoperative pneumonia and bacterial pneumonia (2 arms), sponsored by Parc de Salut Mar. Primary endpoint: Meropenem concentration in epithelial lining fluid (ELF). Started Dec 2016; status: active.
02
Drugs
meropenem
03
Conditions
postoperative pneumoniabacterial pneumonia
Beyond the preview
Go deeper on 2016-002796-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002796-10.